Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives

British Journal of Pharmacology

Volumn 117, Issue 3, 1996, Pages 401-406

  Kankaanranta, H ^a   Rydell, E ^b   Petersson, A S ^c   Holm, P ^a   Moilanen, E ^a   Corell, T ^d   Karup, G ^d   Vuorinen, P ^a,e   Pedersen, S B ^d   Wennmalm, A ^c   Metsa Ketela T ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d A/S GEA Farmaceutisk Fabrik   (Denmark)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

5 cyclic monophosphate; Guanosine 3 ; Mesoionic 3 aryl substituted oxatriazoles; Nitric oxide; Nitric oxide releasing compounds; Platelets

Indexed keywords

3 (3 CHLORO 2 METHYLPHENYL) 5 (4 METHYLBENZENESULFONYLIMINO) 1,2,3,4 OXATRIAZOLE; 3 (3,4 DICHLOROPHENYL) 1,2,3,4 OXATRIAZOLE 5 IMINE; ADENOSINE PHOSPHATE; BUFFER; CYCLIC GMP; IMINE; LINSIDOMINE; METHEMOGLOBIN; N ACETYL S NITROSOPENICILLAMINE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE; OXYHEMOGLOBIN; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG; ZAPRINAST;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PLASMA; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION;

BLOOD PLATELETS; CHEMILUMINESCENT MEASUREMENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC GMP; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; METHEMOGLOBIN; NITRATES; NITRIC OXIDE; NITRITES; OXYHEMOGLOBINS; PLATELET AGGREGATION; TRIAZOLES;

EID: 0030042802     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15204.x     Document Type: Article

References (34)

1. ÄNGGÅRD, E. (1994). Nitric oxide: mediator, murderer, and medicine. Lancet, 343, 1199-1206.
2. ARCHER, S. (1993). Measurement of nitric oxide in biological models. FASEB J., 7, 349-360.
3. COHEN, D.S., MATHIS, J.E. & DOTSON, R.A. (1995). GFA 3175, a novel nitric oxide (NO) donor: a comparison with sodium nitroprusside. FASEB J., 9, A923.
4. CORELL, T., PEDERSEN, S.B., LISSAU, B., MOILANEN, E., METSÄ-KETELÄ, T., KANKAANRANTA, H., VUORINEN, P., VAPAATALO, H., RYDELL, E., ANDERSSON, R., MARCINKIEWICZ, E., KORBUT, R. & GRYGLEWSKI, R.J. (1994). Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol. J. Pharmacol., 46, 553-566.
5. FEELISCH, M. (1991). The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions, J. Cardiovasc. Pharmacol., 17 (Suppl. 3), S25-S33.
6. FEELISCH, M. (1993). Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators. Eur. Heart J., 14, (Suppl. 1), 123-132.
7. FEELISCH, M. & NOACK, E.A. (1987). Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol., 139, 19-30.
8. FEELISCH, M., SCHÖNAFINGER, K. & NOACK, E. (1992). Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans. Biochem. Pharmacol., 44, 1149-1157.
9. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
10. HENRY, Y., LEPOIVRE, M., DRAPIER, J.-C., DUCROCQ, C., BOUCHER, J.-L. & GUISSANI, A. (1993). EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J., 7, 1124-1134.
11. HOGG, N., DARLEY-USMAR, V.M., WILSON, M.T. & MONCADA, S. (1992). Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem. J., 281, 419-424.
12. IGNARRO, L.J., BUGA, G.M., WOOD, K.S., BYRNS, R.E. & CHAUDHURI, G. (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A., 84, 9265-9269.
13. KANKAANRANTA, H., RYDELL, E., PETERSSON, A.-S., HOLM, P., CORELL, T., KARUP, G., MOILANEN, E., VUORINEN, P., PEDERSEN, S.B., WENNMALM, Å. & METSÄ-KETELÄ, T. (1995). Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives GEA 3162 and 3175. Pharmacol. Toxicol., 76 (Suppl. II), 29.
14. KARUP, G., PREIKSCHAT, H., WILHELMSEN, E.S., PEDERSEN, S.B., MARCINKIEWICZ, E., CIESLIK, K. & GRYGLEWSKI, R.J. (1994). Mesoionic oxatriazole derivatives- a new group of NO-donors. Pol. J. Pharmacol., 46, 541-552.
15. KIECHLE, F.L. & MALINSKI, T. (1993). Nitric oxide. Biochemistry, pathophysiology, and detection. Am. J. Clin. Pathol., 100, 567-575.
16. KITA, Y., HIRASAWA, Y., MAEDA, K., NISHIO, M, & YOSHIDA, K. (1994). Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur. J. Pharmacol., 257, 123-130.
17. KNOWLES, R.G. & MONCADA, S. (1994). Nitric oxide synthases in mammals. Biochem. J., 298, 249-258.
18. MALO-RANTA, U., YLÄ-HERTTUALA, S., METSÄ-KETELÄ, T., JAAKKOLA, O., MOILANEN, E., VUORINEN, P. & NIKKARI, T. (1994). Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein, FEBS Lett., 337, 179-183.
19. MARAGOS, C.M., MORLEY, D., WINK, D.A., DUNAMS, T.M., SAAVEDRA, J.E., HOFFMAN, A., BOVE, A.A., ISAAC, L., HRABIE, J.A. & KEEFER, J. (1991). Complexes of .NO with nucleofiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Med. Chem., 34, 3242-3247.
20. MEDANA, C., ERMONDI, G., FRUTTERO, R., DI STILO, A., FERRETTI, C. & GASCO, A. (1994). Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation. J. Med. Chem., 37, 4412-4416.
21. MOILANEN, E., AROLA, O., MALO-RANTA, U., YLÄ-HERTTUALA, S., VUORINEN, P., METSÄ-KETELÄ, T. & VAPAATALO, H. (1994). Nitric oxide donors inhibit neutrophil adhesion to endothelial cells. In Nitric Oxide, Enzymology and Biochemistry, ed. Moncada, S., Feelisch, M., Busse, R. & Higgs, E.A., vol. IV, pp. 271-275. London: Portland Press.
22. MOILANEN, E. & VAPAATALO, H. (1995). Nitric oxide in inflammation and immune response. Ann. Med., 27, 359-367.
23. MOILANEN, E., VUORINEN, P., KANKAANRANTA, H., METSÄ-KETELÄ, T. & VAPAATALO, H. (1993). Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br. J. Pharmacol., 109, 852-858.
24. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
25. MÜLSCH, A., HECKER, M., MORDVINTCEV, P.I., VANIN, A.F. & BUSSE., R. (1993). Enzymic and nonenzymic release of NO accounts for the vasodilator activity of the metabolites of CAS 936, a novel long-acting sydnonimine derivative. Naunyn-Schmied. Arch. Pharmacol., 347, 92-100.
26. PALMER, R.M.J., ASHTON, D.S. & MONCADA, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-666.
27. PALMER, R.M.J., FERRIGE, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524-526.
28. SALAS, E., MORO, M.A., ASKEW, S., HODSON, H.F., BUTLER, A.R., RADOMSKI, M.W. & MONCADA, S. (1994). Comparative pharmacology of analogues of S-nitroso-N-acelyl-DL-penicillamine on human platelets. Br. J. Pharmacol., 112, 1071-1076.
29. SCHMIDT, K., KLATT, P. & MAYER, B. (1994). Reaction of peroxynitrite with oxyhaemoglobin: interference with photometrical determination of nitric oxide. Biochem. J., 301, 645-647.
30. STEINER, A.L., PARKER, C.W. & KIPNIS, D.M. (1972). Radioimmunoassay for cyclic nucleotides. J. Biol. Chem., 247, 1106-1113.
31. VILPO, J.A., VILPO, L.M., VUORINEN, P., MOILANEN, E. & METSÄ-KETELÄ, T. (1994). Cytotoxicity of mesoionic oxatriazoles: a novel series of nitric oxide donors. In Nitric Oxide, Enzymology and Biochemistry, ed. Moncada, S., Feelisch, M., Busse, R. & Higgs, E.A., vol. IV, pp. 286-291. London: Portland Press.
32. VIRTA, M., KARP, M. & VUORINEN, P. (1994). Nitric oxide donor-mediated killing of bioluminescent Escherichia coli. Antimicrob. Agents Chemother., 38, 2775-2779.
33. WENNMALM, Å. (1994). Endothelial nitric oxide and cardiovascular disease. J. Intern. Med., 235, 317-327.
34. WENNMALM, Å., LANNE, B. & PETERSSON, A.-S. (1990). Detection of endothelial-derived relaxing factor in human plasma in the basal state and following ischemia using electron paramagnetic resonance spectrometry. Anal. Biochem., 187, 359-363.